NCT05584332 2023-07-21
A Phase â…¢ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3 Terminated
Shanghai Bovax Biotechnology Co., Ltd.
GOG Foundation
National Cancer Institute (NCI)
Asan Medical Center
Japan Clinical Oncology Group
M.D. Anderson Cancer Center
Columbia University
Duke University
GOG Foundation
UNICANCER